Menopause Drugs: Study Stokes New Debate Over Cancer Risks

Women who start hormone replacement therapy (HRT) soon after menopause do not show higher cancer incidence within 16 years, according to a Danish study published on Tuesday that fuels scientific discord over the treatment's safety.

Indeed, women who took HRT in the investigation had a significantly lower risk of dying or developing heart problems, the researchers wrote in a paper published on the medical website bmj.com.

The new study was hailed by a menopause awareness group, but a researcher who led a wider probe into HRT said it was worryingly underpowered.

HRT has been shrouded in controversy since a Women's Health Initiative (WHI) study in 2002 reported a higher risk of breast cancer for women who take it, a finding echoed by the Million Women Study (MWS) a year later.

"We found a significantly decreased risk of... death, heart failure or myocardial infarction (heart attack) when hormone replacement therapy was started early in postmenopause," wrote the Danish team.

"(...) (T)his finding was not associated with an increased risk of cancer, stroke, deep vein thrombosis, or pulmonary embolism." The MWS stirred up a storm when it claimed HRT boosted cancer risk by between 30 and 100 percent, a finding criticized by other scientists who claimed the study method was flawed.

HRT uses the female hormones estrogen or progestogen, sometimes combined, to ease menopausal symptoms such as hot flashes, loss of sex drive, and vaginal dryness. The new study looked at 1,006 recently postmenopausal women, of whom 502 were given HRT and 504 no treatment.

Apart from the HRT group being 5.7 months older, there were no other significant differences between the groups in things like weight, health, or smoking habits.  

References
Study stokes new debate over cancer risk
https://www.health24.com/Medical/Menopause/News/Study-stokes-new-debate-over-cancer-risk-20130210

Hormone therapy 'not a cancer risk', new study finds

https://www.news.com.au/world/hormone-therapy-not-a-cancer-risk-new-study-finds/news-story/e6bd425d998a7ee480937cbecaef0c7e

Contact Us Today For A Free Consultation

Name *

Email *

Phone *

Your Program *HGH TherapyHGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender DysmorphiaBlood ServicesTesamorelinOther

Your State *United StatesAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada

Select Age (30+ only) *Over 2930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475+

* Required

Dear Patient,

Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.

Please call now: 1-800-380-5339.

Welcoming You To Our Clinic, Professor Tom Henderson.